|
|
Gene Transfer |
| Methotrexate resistance conferred by transplantation of drug-resistant transgenic marrow cells fractionated bycounterflow elutriation |
815 |
| RI James,
C May,
MD Diers,
JE Wagner & RS McIvor
|
|
Abstract
Full Article (PDF)
|
|
T-Cell Depletion |
| Effect on cytokine release and graft-versus-host disease of different anti-T cell antibodies during conditioning for unrelated haematopoietic stem cell transplantation |
823 |
| M Remberger,
B-M Svahn,
P Hentschke,
C Löfgren & O Ringdén
|
|
Abstract
Full Article (PDF)
|
|
Cytokines And Growth Factors |
| A prospective randomized trial of Filgrastim (r-metHuG-CSF) given at different times after unrelated bone marrow transplantation |
831 |
| H Hägglund,
O Ringdén,
S Öman,
M Remberger,
S Carlens & J Mattsson
|
|
Abstract
Full Article (PDF)
|
|
Breast Cancer |
| Myeloablative chemotherapy with autologous peripheral blood stem cell transplantation for metastatic breast cancer: immunologic consequences affecting clinical outcome |
837 |
| NG Chakraborty,
S Bilgrami,
LJ Maness,
C Guo,
A Perez-Diez,
B Mukherji & P Tutschka
|
|
Abstract
Full Article (PDF)
|
|
Aplastic Anaemia |
| High-dose peripheral blood stem cell transplant for multitransfused severe aplastic anaemia patients without antithymocyte globulin in the conditioning regimen |
845 |
| JL Herrera-Garza,
JC Jaime-Pérez,
JL Montemayor,
RE Ibarra-Peart & D Gómez-Almaguer
|
|
Abstract
Full Article (PDF)
|
|
Fanconi Anaemia |
| Bone marrow transplantation for patients with Fanconi anemia: reduced doses of cyclophosphamide without irradiation as conditioning |
849 |
| CR de Medeiros,
J Zanis-Neto & R Pasquini
|
|
Abstract
Full Article (PDF)
|
|
Amyloid |
| High treatment-related mortality in cardiac amyloid patients undergoing autologous stem cell transplant |
853 |
| N Saba,
DM Sutton,
HJ Ross,
S Siu,
RM Crump,
A Keating & AK Stewart
|
|
Abstract
Full Article (PDF)
|
|
Graft Versus Host Disease |
| Use of a skin explant model for predicting GVHD in HLA-matched bone marrow transplants - effect of GVHD prophylaxis |
857 |
AM Dickinson,
I Hromadníková,
L Sviland,
GH Jackson,
PRA Taylor,
J Vav inec,
P Sedlá ek,
M ermáková,
J Starý,
A Vítek,
J Sajdová & SJ Proctor
|
|
Abstract
Full Article (PDF)
|
|
Purging |
| High-dose therapy supported with immunomagnetic purged autologous bone marrow in high-grade B cell non-Hodgkin’s lymphoma |
865 |
| AK Blystad,
G Kvalheim,
E Torlakovic,
H Holte,
E Jacobsen,
K Beiske,
H Vålerhaugen,
E Lenschow & S Kvaløy
|
|
Abstract
Full Article (PDF)
|
|
Immune Reconstitution |
| Persistent changes in the immune system 4-10 years after ABMT |
873 |
| T Nordøy,
A Kolstad,
P Endresen,
H Holte,
S Kvaløy,
G Kvalheim & A Husebekk
|
|
Abstract
Full Article (PDF)
|
|
Miscellaneous Complications |
| High-dose corticosteroid therapy for diffuse alveolar hemorrhage in allogeneic bone marrow stem cell transplant recipients |
879 |
| A Raptis,
D Mavroudis,
AF Suffredini,
J Molldrem,
F Van Rhee,
R Childs,
S Phang & AJ Barrett
|
|
Abstract
Full Article (PDF)
|
|
| Bone mineral density after allogeneic bone marrow transplantation |
885 |
| M Kauppila,
K Irjala,
P Koskinen,
K Pulkki,
P Sonninen,
J Viikari & K Remes
|
|
Abstract
Full Article (PDF)
|
|
| Late onset veno-occlusive disease following high-dose chemotherapy and stem cell transplantation |
891 |
| HC Toh,
SL McAfee,
R Sackstein,
BF Cox,
C Colby & TR Spitzer
|
|
Abstract
Full Article (PDF)
|
|
| A prospective randomized trial comparing the toxicity and safety of atovaquone with trimethoprim/sulfamethoxazole as Pneumocystis carinii pneumonia prophylaxis following autologous peripheral blood stem cell transplantation |
897 |
| C Colby,
SL McAfee,
R Sackstein,
DM Finkelstein,
JA Fishman & TR Spitzer
|
|
Abstract
Full Article (PDF)
|
|
Psychosocial Evaluation |
| Assessment of psychosocial adjustment in Chinese unrelated bone marrow donors |
903 |
| A Molassiotis & E Holroyd
|
|
Abstract
Full Article (PDF)
|
|
Quality Of Life |
| Do patients who are treated with stem cell transplantation have a health-related quality of life comparable to the general population after 1 year? |
911 |
| MJ Hjermstad,
H Holte,
SA Evensen,
PM Fayers & S Kaasa
|
|
Abstract
Full Article (PDF)
|
|
Case Reports |
| Thrombotic microangiopathy associated with reactivation of human herpesvirus-6 following high-dose chemotherapy with autologous bone marrow transplantation in young children |
919 |
| Y Matsuda,
J Hara,
H Miyoshi,
Y Osugi,
H Fujisaki,
K Takai,
H Ohta,
K Tanaka-Taya,
K Yamanishi & S Okada
|
|
Abstract
Full Article (PDF)
|
|
| Graft-versus-myeloma after withdrawal of immunosuppression following allogeneic peripheral stem cell transplantation |
925 |
| J Libura,
T Hoffmann,
JR Passweg,
M Gregor,
G Favre,
A Tichelli & A Gratwohl
|
|
Abstract
Full Article (PDF)
|
|
| Autologous peripheral blood stem cell transplantation for Waldenstrom’s macroglobulinemia |
929 |
| L Yang,
BP Wen,
HM Li,
MB Yang,
YH Jin,
SY Yang & JH Tao
|
|
Abstract
Full Article (PDF)
|
|
| Successful bone marrow transplantation in a case of Griscelli disease which presented in accelerated phase with neurological involvement |
931 |
 Tezcan,
Ö Sanal,
F Ersoy,
D Uckan,
 Klç,
A Metin,
M Cetin,
R Akn,
C Öner & AM Tuncer
|
|
Abstract
Full Article (PDF)
|
|
| Hematopoietic stem cell transplantation (HSCT) for Langerhans cell histiocytosis (LCH) in Japan |
935 |
| N Kinugawa,
S Imashuku,
Y Hirota,
K Yamada,
A Yamamoto,
A Akazai,
M Oda,
N Miura,
H Kakuta,
T Sato,
M Endo & T Takano
|
|
Abstract
Full Article (PDF)
|
|
